1. Home
  2. GKOS vs CWST Comparison

GKOS vs CWST Comparison

Compare GKOS & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CWST
  • Stock Information
  • Founded
  • GKOS 1998
  • CWST 1975
  • Country
  • GKOS United States
  • CWST United States
  • Employees
  • GKOS N/A
  • CWST N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CWST Environmental Services
  • Sector
  • GKOS Health Care
  • CWST Utilities
  • Exchange
  • GKOS Nasdaq
  • CWST Nasdaq
  • Market Cap
  • GKOS 5.8B
  • CWST 6.5B
  • IPO Year
  • GKOS 2015
  • CWST 1997
  • Fundamental
  • Price
  • GKOS $89.83
  • CWST $99.34
  • Analyst Decision
  • GKOS Strong Buy
  • CWST Strong Buy
  • Analyst Count
  • GKOS 12
  • CWST 7
  • Target Price
  • GKOS $131.17
  • CWST $123.17
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • CWST 585.2K
  • Earning Date
  • GKOS 07-30-2025
  • CWST 07-31-2025
  • Dividend Yield
  • GKOS N/A
  • CWST N/A
  • EPS Growth
  • GKOS N/A
  • CWST N/A
  • EPS
  • GKOS N/A
  • CWST 0.18
  • Revenue
  • GKOS $432,953,000.00
  • CWST $1,721,548,000.00
  • Revenue This Year
  • GKOS $27.88
  • CWST $18.35
  • Revenue Next Year
  • GKOS $27.76
  • CWST $7.22
  • P/E Ratio
  • GKOS N/A
  • CWST $559.91
  • Revenue Growth
  • GKOS 26.70
  • CWST 20.35
  • 52 Week Low
  • GKOS $77.10
  • CWST $97.05
  • 52 Week High
  • GKOS $163.71
  • CWST $121.24
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • CWST 31.11
  • Support Level
  • GKOS $88.94
  • CWST $97.85
  • Resistance Level
  • GKOS $92.70
  • CWST $100.43
  • Average True Range (ATR)
  • GKOS 3.82
  • CWST 2.56
  • MACD
  • GKOS 0.38
  • CWST -0.21
  • Stochastic Oscillator
  • GKOS 46.71
  • CWST 11.39

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

Share on Social Networks: